Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Verrica Pharmaceuticals buy Jefferies Financial Group Inc.

Verrica Pharmaceuticals
Start price
€5.10
15.12.23 / 50%
Target price
€9.18
15.12.24
Performance (%)
-86.93%
End price
€0.67
16.12.24
Summary
This prediction ended on 16.12.24 with a price of €0.67. Massive losses of -86.93% were the result for the BUY prediction by Jefferies_Financial_. Jefferies_Financial_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Verrica Pharmaceuticals - - -
iShares Core DAX® -1,06 % 5,01 % 6,60 %
iShares Nasdaq 100 -2,39 % 0,86 % 25,79 %
iShares Nikkei 225® -4,36 % 1,21 % 41,31 %
iShares S&P 500 -1,78 % 1,39 % 21,04 %

Comments by Jefferies_Financial_ for this prediction

In the thread Discuss Verrica Pharmaceuticals
Prediction Buy
Perf. (%) -86.93%
Target price 9.178
Change
Ends at 15.12.24

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $10.00 price target on the stock.
Ratings data for VRCA provided by MarketBeat

Jefferies Financial Group Inc. 
0
Report Share
15.12.23
In the thread Trading Verrica Pharmaceuticals
Prediction Buy
Perf. (%) -86.93%
Target price 9.178
Change
Ends at 15.12.24

Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten

Jefferies Financial Group Inc. 
0
Report Share
16.12.24